ASCL1 and cancer: Subsequently, we validated the most potent markers (ASCL1, LHX8, SST, WDR17, ZIC1 and ZNF582) in a large independent series, confirmed the accuracy (AUC = 0.89) and showed that high methylation levels are associated with progression towards cancer.